Global Health Ventures To Develop Fast Acting Anti-Stress Medication

Main Category: Anxiety / Stress
Article Date: 13 May 2010 - 0:00 PDT


Global Health Ventures Inc. (OTCBB:GHLV) (the "Company") is pleased to announce that, it has targeted the development of a new anti-stress medication "Relax-B" using its proprietary sublingual technology. The Company's lead therapeutic product "X-Excite" (male sexual enhancement drug) is already proceeding successfully through the clinical trials. The Company has initiated the development of a second drug "Relax-B" designed to cause relaxation of muscles leading to stress relief. The new product uses an already FDA approved drug with a special formulation at a very low dosage that reaches blood rapidly.

The anti-stress market is estimated to be over $5 billion and is currently growing at an unprecedented rate due to socio-economic problems associated with our daily life. While there is no cure, the effective treatment can provide people with better life and greater productivity. Stress or depression is a chronic disease that can involve lifetime intervention. While currently almost all the anti-stress medications are acting slow and sometimes require months for patients to see the effect, the need for rapid anti-stress medications is highly desirable. We are focused on developing such rapid acting medications as our unique technology allows us to develop such products.

Source
Global Health Ventures

• Additional
• References
• Citations